NYSE:MRO

Marathon Oil (MRO)

28.55
-0.00 (0.00%)
as of Nov 21, 2024, 12:00:00 am Market Open.
34 watching
0
Investor Insights
star iconSep 6, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Marathon Oil (MRO-N) has shown impressive performance, rising 33% over the past six months, which has prompted some investors to re-enter or increase their positions in the stock. The company's valuation at a low price-to-earnings ratio of 14 times earnings makes it an attractive investment opportunity, particularly among growth-oriented and value-seeking investors. Additionally, Marathon Oil offers a dividend yield of 2%, which has been consistently increasing by 15% annually over the last three years, indicating the management's commitment to returning capital to shareholders. The company is also engaging in share buybacks, further enhancing shareholder value and demonstrating confidence in its future prospects. Overall, the combination of strong performance, healthy dividends, and strategic buybacks presents a compelling case for those considering investing in Marathon Oil.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
PXD
PAST TOP PICK
(A Top Pick July 10/06. Up 18.3%.) a valuation call. Pretty good refining fundamentals. Upstream production also started to come on. Still attractive.
TOP PICK
Extremely cheap on a cash flow multiple basis. Trades at about 3.7 EBITDA. Has a very strong downstream in refining component. Visible production growth.
TOP PICK
Basically an international story. Likes the improving production profile their downstream arm, Marathon Ashland which is their refinery.
PAST TOP PICK
(A Top Pick Feb 15/05. Up 5%.) Things have pulled back a little over the last few weeks, but still pleased with this one. Should go higher.
TOP PICK
Very, very cheap compared to its peers. Has an improving capital employed story. Improving cash flow and efficiency. Good yhield.
DON'T BUY
Third-quarter results have been reasonable but not outstanding. Doesn't have a large institutional following. Expects it will have a bit of a struggle. Fairly reasonably valued at this point. Not a lot of upside.
Showing 31 to 36 of 36 entries